144 related articles for article (PubMed ID: 1686817)
1. Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder.
Lesch KP; Hoh A; Schulte HM; Osterheider M; Müller T
Psychopharmacology (Berl); 1991; 105(3):415-20. PubMed ID: 1686817
[TBL] [Abstract][Full Text] [Related]
2. 5-HT1A receptor-effector system responsivity in panic disorder.
Lesch KP; Wiesmann M; Hoh A; Müller T; Disselkamp-Tietze J; Osterheider M; Schulte HM
Psychopharmacology (Berl); 1992; 106(1):111-7. PubMed ID: 1346719
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls.
Lesch KP; Hoh A; Disselkamp-Tietze J; Wiesmann M; Osterheider M; Schulte HM
Arch Gen Psychiatry; 1991 Jun; 48(6):540-7. PubMed ID: 1674853
[TBL] [Abstract][Full Text] [Related]
4. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ
Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
[TBL] [Abstract][Full Text] [Related]
5. Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression.
Lesch KP; Mayer S; Disselkamp-Tietze J; Hoh A; Schoellnhammer G; Schulte HM
Life Sci; 1990; 46(18):1271-7. PubMed ID: 1971701
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge.
Lerer B; Gelfin Y; Gorfine M; Allolio B; Lesch KP; Newman ME
Neuropsychopharmacology; 1999 Jun; 20(6):628-39. PubMed ID: 10327431
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A receptor responsivity in anxiety disorders and depression.
Lesch KP
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):723-33. PubMed ID: 1763190
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats.
Li Q; Brownfield MS; Levy AD; Battaglia G; Cabrera TM; Van de Kar LD
Biol Psychiatry; 1994 Sep; 36(5):300-8. PubMed ID: 7993956
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls.
Lesch KP; Mayer S; Disselkamp-Tietze J; Hoh A; Wiesmann M; Osterheider M; Schulte HM
Biol Psychiatry; 1990 Oct; 28(7):620-8. PubMed ID: 1977479
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
Cleare AJ; Forsling M; Bond AJ
Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364
[TBL] [Abstract][Full Text] [Related]
11. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects.
Price LH; Cappiello A; Malison RT; McDougle CJ; Pelton GH; Schöllnhammer G; Heninger GR
Neuropsychopharmacology; 1997 Oct; 17(4):246-57. PubMed ID: 9326749
[TBL] [Abstract][Full Text] [Related]
12. Effects of divalproex sodium on 5-HT1A receptor function in healthy human males: hypothermic, hormonal, and behavioral responses to ipsapirone.
Shiah IS; Yatham LN; Lam RW; Zis AP
Neuropsychopharmacology; 1997 Dec; 17(6):382-90. PubMed ID: 9397426
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
Hollander E; DeCaria C; Gully R; Nitescu A; Suckow RF; Gorman JM; Klein DF; Liebowitz MR
Psychiatry Res; 1991 Jan; 36(1):1-17. PubMed ID: 2017519
[TBL] [Abstract][Full Text] [Related]
14. Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls.
Yatham LN; Shiah IS; Lam RW; Tam EM; Zis AP
J Affect Disord; 1999 Aug; 54(3):295-301. PubMed ID: 10467974
[TBL] [Abstract][Full Text] [Related]
15. The 5-HT receptor--G-protein--effector system complex in depression. I. Effect of glucocorticoids.
Lesch KP; Lerer B
J Neural Transm Gen Sect; 1991; 84(1-2):3-18. PubMed ID: 1647169
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL
Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists.
Lesch KP; Söhnle K; Poten B; Schoellnhammer G; Rupprecht R; Schulte HM
J Clin Endocrinol Metab; 1990 Mar; 70(3):670-4. PubMed ID: 1968468
[TBL] [Abstract][Full Text] [Related]
18. Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and CREB pathway.
Arora T; Bhowmik M; Khanam R; Vohora D
Behav Brain Res; 2013 Jun; 247():146-52. PubMed ID: 23473877
[TBL] [Abstract][Full Text] [Related]
19. Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results.
Broocks A; Pigott TA; Hill JL; Canter S; Grady TA; L'Heureux F; Murphy DL
Psychiatry Res; 1998 Jun; 79(1):11-20. PubMed ID: 9676822
[TBL] [Abstract][Full Text] [Related]
20. The effects of gepirone on neuroendocrine function and temperature in humans.
Anderson IM; Cowen PJ; Grahame-Smith DG
Psychopharmacology (Berl); 1990; 100(4):498-503. PubMed ID: 2157231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
